Adam Tomasi - 15 May 2025 Form 4 Insider Report for Allakos Inc. (ALLK)

Role
President
Signature
/s/ H. Baird Radford, III, by power of attorney
Issuer symbol
ALLK
Transactions as of
15 May 2025
Net transactions value
$0
Form type
4
Filing time
15 May 2025, 16:08:04 UTC
Previous filing
07 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tomasi Adam President 149 COMMONWEALTH DR, SUITE 1090, MENLO PARK /s/ H. Baird Radford, III, by power of attorney 15 May 2025 0001637219

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLK Common Stock Disposed to Issuer -512,630 -100% 0 15 May 2025 Direct F1, F2
transaction ALLK Common Stock Disposed to Issuer -20,790 -100% 0 15 May 2025 See footnote F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -486,400 -100% $0.000000 0 15 May 2025 Common Stock 486,400 $0.6900 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -145,011 -100% $0.000000 0 15 May 2025 Common Stock 145,011 $4.01 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -88,036 -100% $0.000000 0 15 May 2025 Common Stock 88,036 $4.31 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -125,000 -100% $0.000000 0 15 May 2025 Common Stock 125,000 $35.28 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -300,471 -100% $0.000000 0 15 May 2025 Common Stock 300,471 $7.20 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -1,200,000 -100% $0.000000 0 15 May 2025 Common Stock 1,200,000 $1.25 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Adam Tomasi is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Includes 190,270 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer.
F2 Disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc. (the "Merger Agreement") in exchange for $0.33 in cash per share.
F3 The shares are held by Mr. Tomasi and Carrie Tomasi, as Trustees of the Tomasi Living Trust dated July 14, 2017.
F4 This option was cancelled without consideration pursuant to the terms of the Merger Agreement.